{"altmetric_id":4662871,"counts":{"readers":{"mendeley":11,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["GoToPER","CancerPapers"],"posts_count":2}},"selected_quotes":["A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a\u2026 #breastcancer"],"citation":{"altmetric_jid":"4f6fa4e83cf058f610002280","authors":["Grellety, T","Soubeyran, I","Robert, J","Bonnefoi, H","Italiano, A"],"doi":"10.1093\/annonc\/mdv496","endpage":"200","first_seen_on":"2015-10-22T20:18:32+00:00","funders":["niehs"],"issns":["1569-8041","0923-7534"],"issue":"1","journal":"Annals of Oncology","last_mentioned_on":1474627569,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26487584?dopt=Abstract&utm_medium=twitter","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26487584?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"26487584","pubdate":"2015-10-22T22:00:35+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"199","subjects":["neoplasms"],"title":"A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2 directed therapy.","type":"article","volume":"27","mendeley_url":"http:\/\/www.mendeley.com\/research\/clinical-case-invasive-lobular-breast-carcinoma-erbb2-cdh1-mutations-presenting-dramatic-response-an"},"altmetric_score":{"score":0.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.75},"context_for_score":{"all":{"total_number_of_other_articles":8422812,"mean":7.0866213065837,"rank":6089442,"this_scored_higher_than_pct":24,"this_scored_higher_than":2031467,"rank_type":"exact","sample_size":8422812,"percentile":24},"similar_age_3m":{"total_number_of_other_articles":245761,"mean":9.7066701009113,"rank":152179,"this_scored_higher_than_pct":31,"this_scored_higher_than":77941,"rank_type":"exact","sample_size":245761,"percentile":31},"this_journal":{"total_number_of_other_articles":3626,"mean":9.7335525517241,"rank":2785,"this_scored_higher_than_pct":19,"this_scored_higher_than":705,"rank_type":"exact","sample_size":3626,"percentile":19},"similar_age_this_journal_3m":{"total_number_of_other_articles":167,"mean":6.0857590361446,"rank":97,"this_scored_higher_than_pct":38,"this_scored_higher_than":64,"rank_type":"exact","sample_size":167,"percentile":38}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":3,"Researcher":1,"Other":4,"Student  > Master":3},"by_discipline":{"Medicine and Dentistry":5,"Agricultural and Biological Sciences":3,"Unspecified":3}}},"geo":{"twitter":{"US":1},"mendeley":{"GB":1,"AU":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/GoToPER\/statuses\/657289890682376193","license":"gnip","citation_ids":[4662871],"posted_on":"2015-10-22T20:18:16+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"657289890682376193"},{"url":"http:\/\/twitter.com\/CancerPapers\/statuses\/779270625160376320","license":"gnip","citation_ids":[4662871],"posted_on":"2016-09-23T10:46:09+00:00","author":{"name":"Cancer Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/610454165983244288\/dcwghekI_normal.jpg","description":"Stay abreast of the latest developments in the fight against cancer with daily publications curated from PubMed.","id_on_source":"CancerPapers","tweeter_id":"3326766226","geo":{"lt":null,"ln":null},"followers":722},"tweet_id":"779270625160376320"}]}}